Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
about
Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization)Oral cavity and oropharyngeal squamous cell carcinoma--an updateLow-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocolsIntensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.Nomogram for predicting symptom severity during radiation therapy for head and neck cancer.Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma.Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancerInvestigating the clinical significance of body composition changes in patients undergoing chemoradiation for oropharyngeal cancer using analytic morphomics.Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI.Head and Neck Cancers, Version 1.2015.Feeding Tube Utilization in Patients with Salivary Gland Malignancies.Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it.Functional outcomes after TORS for oropharyngeal cancer: a systematic reviewA systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review.Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma.Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer.The management of head and neck tumors with high technology radiation therapy.Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology RaQuality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTPredicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy.Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk.Can xerostomia be further reduced by sparing parotid stem cells?Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation.Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors.Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.Treatment of late sequelae after radiotherapy for head and neck cancer.Experiences of Head and Neck Cancer Patients in Middle Adulthood: Consequences and Coping.Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy.Application of the International Classification of Functioning, Disability and Health (ICF) to people with dysphagia following non-surgical head and neck cancer management.Hazards of sparing the ipsilateral parotid gland in the node-positive neck with intensity modulated radiation therapy: Spatial analysis of regional recurrence risk.
P2860
Q26796524-560B4527-B324-4474-8A68-6D6D31BF8D84Q26799210-17310CC9-200C-472A-BD87-52B1F47B3144Q30355452-E77B746C-54FA-4E2A-8C99-8BA9975B87A3Q33809126-26B6C61A-2641-4E3C-8383-7B1FFE1EF895Q34287961-82A5CBC5-1BE0-49D4-8DAE-40C3DF3A4E26Q35372786-B8D60AE8-61F2-4022-B981-075006C97C28Q35627159-B1E08BDA-9876-402A-96B1-2D850DBFC8B6Q36156806-2FA656EC-5E97-447C-943E-024DB0E8B688Q36788868-F5F0E43C-F796-4224-B79E-D1F305626EDFQ36985236-A74D4C6D-E7FC-4376-8827-403FFA2F7A27Q37157739-947D5413-132B-4F4B-A6EC-DCD0028C13BDQ37553089-0E532BDE-0EEA-42A0-89D7-8C6C7BCE238FQ37672535-1BF1B735-8B29-421C-ADE4-72A005B900D3Q38197122-BD73DAB1-9589-4A92-A3B2-8DEB91E7B70DQ38204303-EC2F256B-7489-44C4-8C03-0104599A1F82Q38252802-E6049B2A-F084-4852-8FE4-38EDB4439757Q38267294-98DE0CCE-F92F-444A-B1B4-A1B0C49A5B72Q38381626-A8E76786-57D1-467E-AD06-DCDB9D0CEF1EQ38411314-B1D19E28-C9A8-429F-A9FF-CB612C912012Q38835143-ACBF3634-ADCF-4336-97EB-DD330987C63EQ38881581-92140E37-05D4-4724-B8DD-8EF7A71F92E9Q39302912-4CAACE05-F97C-4FA0-B77B-79079A6B87A0Q39302927-8BCD0736-A376-492A-A4F3-7D80278794B9Q39578584-2556342A-9DAD-4A1D-90F2-54267DE07A32Q40049755-D293975A-4908-410F-8AB7-0B8985A6802AQ40098364-BFF601DA-1303-4E27-AB2F-A5359592F4E9Q40847456-6B6AF3BE-1B81-40E7-AB4A-855AEDE5A04EQ41891737-5BFD9455-D888-4A49-B285-011047DBB804Q42370333-A7691C36-33F8-4B79-A017-94907F666B35Q43834166-960A8DDA-57F2-4171-9D2E-AD9C92C87868Q46326125-03C82488-F576-4312-B020-5359B52E8206Q46408955-77AECC21-C44A-4272-B425-756FF5D68DE4Q47307047-108F3D5B-5776-4F04-A916-E348A39B04F8Q48005691-CF95659A-FE8F-439C-8C84-AC0FA0BC2E92Q48046907-00816780-E58D-4FE0-B7FA-62956ED7E9A2Q50307416-86244C19-E03E-4E18-8244-A2618BBFC6D7Q52345253-29E82F30-4576-4B0C-B2E8-4DDFE911F7D6Q52385231-282B148E-A66D-4057-A5A2-31BAD9BD2A78Q53085927-10CA95C3-594D-4EF2-9E64-309EA2C0C23CQ55385704-1400E0AA-A9E7-49D1-A83B-4F5C7352A8BF
P2860
Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Toxicities affecting quality o ...... rated, and objective outcomes.
@ast
Toxicities affecting quality o ...... rated, and objective outcomes.
@en
type
label
Toxicities affecting quality o ...... rated, and objective outcomes.
@ast
Toxicities affecting quality o ...... rated, and objective outcomes.
@en
prefLabel
Toxicities affecting quality o ...... rated, and objective outcomes.
@ast
Toxicities affecting quality o ...... rated, and objective outcomes.
@en
P2093
P2860
P1476
Toxicities affecting quality o ...... rated, and objective outcomes.
@en
P2093
Benjamin Cornwall
Carol-Anne Murdoch-Kinch
Connie S Y Lee
Douglas B Chepeha
Felix Y Feng
Klaudia U Hunter
Mark Haxer
Teresa Lyden
P2860
P304
P356
10.1016/J.IJROBP.2012.08.030
P407
P577
2012-10-03T00:00:00Z